Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by cytochromeon Apr 16, 2016 1:22pm

125 Views

Post# 24775023

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Just imagine is cell death occurs

Bencro - if the dose is optimal, and enough ROS is present to kill the CA cell, then yes, apopstosis will occur. Feel free to look up those technical terms....
The limitations are it's ability to be absorbed and consequently kill every CA cell. Repeat treatment may be necessary and of course there's a limitation as to deep an effective photo dose can travel.
I'm sure everyone here is aware green light is highly absorbed by Hb of RBCs. limiting its ability to travel very deep. Hence higher wavelengths are necessary. Whihc of course may be an issue wrt its ability to produce high enough concentrations of ROS.

Bencro- I know a wee bit about PDT, so stop your incessant insults.

Bullboard Posts

Gold vs. bitcoin, where should you invest?